This hypothesis-generating study lays the foundational basis for future work involving larger patient cohorts and aiming at disclosing the molecular pathways underpinning prostate carcinogenesis and resistance to chemotherapy induced by obesogen-dysregulated PPAT. The gene discussed is PPAT; the disease is urogenital neoplasm.